en

PRODUCT DETAIL

Repatha 420 mg injekčný roztok v náplni

Code 3164C
MA number EU/1/15/1016/006
Product Form: sol inj 1x3,5 ml/420 mg (náplň plast.+1 minidávk.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 31 - HYPOLIPIDAEMICA
ATC:
C CARDIOVASCULAR SYSTEM
C10 Lipid modifying agents
C10A Lipid modifying agents, plain
C10AX Other lipid modifying agents
C10AX13 Evolocumab
Shelf life: 24
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 17.02.2017
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 27.04.2020
eu-flag.png sk-flag.png